10.99
+0.49(+4.67%)
Currency In USD
| Previous Close | 10.5 |
| Open | 10.51 |
| Day High | 11 |
| Day Low | 10.51 |
| 52-Week High | 14.38 |
| 52-Week Low | 3.9 |
| Volume | 177,149 |
| Average Volume | 366,036 |
| Market Cap | 718.39M |
| PE | -18.02 |
| EPS | -0.61 |
| Moving Average 50 Days | 10.75 |
| Moving Average 200 Days | 9.04 |
| Change | 0.49 |
If you invested $1000 in Bioventus Inc. (BVS) since IPO date, it would be worth $572.1 as of February 05, 2025 at a share price of $10.99. Whereas If you bought $1000 worth of Bioventus Inc. (BVS) shares 3 years ago, it would be worth $877.8 as of February 05, 2025 at a share price of $10.99.
For more details, use our stock calculator to calculate how much you would've made investing different amounts on specific dates.
Bioventus to Present at the 43rd Annual J.P. Morgan Healthcare Conference
GlobeNewswire Inc.
Jan 07, 2025 1:00 PM GMT
DURHAM, N.C., Jan. 07, 2025 (GLOBE NEWSWIRE) -- Bioventus Inc. (Nasdaq: BVS), a global leader in innovations for active healing, today announced that Rob Claypoole, chief executive officer, will present at the 43rd Annual J.P. Morgan Healthcare Con
Bioventus Completes Divestiture of its Advanced Rehabilitation Business to Accelmed Partners
GlobeNewswire Inc.
Jan 02, 2025 1:00 PM GMT
DURHAM, N.C., Jan. 02, 2025 (GLOBE NEWSWIRE) -- Bioventus Inc. (Nasdaq: BVS) (“Bioventus” or the “Company”), a global leader in innovations for active healing, announced today that it has successfully completed the divestiture of its Advanced Rehab
Bioventus Reports Third Quarter Financial Results
GlobeNewswire Inc.
Nov 05, 2024 12:30 PM GMT
Q3 Revenue Advanced by 15.0%, Fourth Straight Quarter of Double Digit Organic* GrowthQ3 Gross Margin Expanded 200 bpsQ3 Cash from Operations of $10.3 million, an Increase of $18.6 million Compared to Previous Year DURHAM, N.C., Nov. 05, 2024 (GLOBE